GBA
IONS icon

Garrison Bradford & Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Garrison Bradford & Associates’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-78,600
Closed -$3.4M – 113
2014
Q1 		$3.4M Sell
78,600
-20,700
-21% -$1M 3.27% 7
2013
Q4 		$3.96M Sell
99,300
-1,400
-1% -$49.9K 3.74% 7
2013
Q3 		$3.78M Buy
100,700
+7,700
+8% +$230K 3.87% 6
2013
Q2 		$2.5M Buy
+93,000
New +$1.98M 2.69% 9

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Garrison Bradford & Associates's IONS Position: Q2 2014 in Review

Garrison Bradford & Associates sold out of Ionis Pharmaceuticals (IONS) in Q2 2014, closing a stake of 78,600 shares — an estimated $3.4M sold.

Garrison Bradford & Associates first reported a position in IONS in Q2 2013 and held it in 4 quarters. The position peaked at $3.96M in Q4 2013. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • Garrison Bradford & Associates reported no remaining Ionis Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Garrison Bradford & Associates sold 78,600 Ionis Pharmaceuticals shares in Q2 2014, an estimated $3.4M.
  • Garrison Bradford & Associates first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Garrison Bradford & Associates's Ionis Pharmaceuticals position peaked at $3.96M in Q4 2013.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on Garrison Bradford & Associates's 13F filing for Q2 2014, filed 14 Jul 2014.